Healthcare & Biotech
Invitris
Creating new protein-based drugs at scale
Invitris radically simplifies how we create novel biological drugs. Our patent-pending technology platform turns DNA into synthetic proteins and was recently featured in the Science magazine. It makes creating new drugs >10,000x more efficient at <100x lower costs of material. Our killer application is enabling the newest generation of…
- Drug Discovery and Delivery
- Biotech
- Nanotechnology
- Website
- invitris.com
- Headquarters
- Munich, BY, Germany
- Team size
- 2-10 people
- Founded
- 2023
- Demo
- 20 min demo
Similar companies
Arpeggio BioArpeggio Bio develops drugs targeting transcription factors using AI…
Talus BioDiscovering drugs that target the DNA regulome
Avro Life ScienceSkin patches for generic drug delivery.
Adventris PharmaceuticalsAdventris makes cancer vaccines
Parallel BioUsing the immune system to cure disease
General ProximityThe next generation of induced-proximity medicines.
Harmonic DiscoveryMulti-targeted therapeutics to treat complex diseases
Synkrino BiotherapeuticsSynkrino's AI, SATIS is a powerful, unbiased discovery system for…